As of April 29, 2025, MiNK Therapeutics (INKT) has a market cap of $31.176 million USD. According to our data, MiNK Therapeutics is ranked No.8366 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $31.18 M |
12.86%
|
Dec 31, 2024 | $27.62 M |
-34.86%
|
Dec 29, 2023 | $42.40 M |
-59.00%
|
Dec 30, 2022 | $0.10 B |
-41.48%
|
Dec 31, 2021 | $0.18 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$44.00 M |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.21 B |
48.381 M
|
![]() France
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
Market Cap | = | INKT Stock Price | * | INKT Shares Outstanding |
= | $7.86 | * | 3.97 M | |
= | $31.18 M |